$0.745500
-0.0062-0.82%
At Close: -
$0.741100
-0.0044-0.59%
After Hours: Jul 5, 6:01 PM EDT
15 minutes delayed
Ovid Therapeutics
OVIDNASDAQ
Ovid Therapeutics (NASDAQ:OVID) Stock, Earnings Estimates, EPS, And Revenue
Ovid Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 14
EPS
$-0.170
Quarterly Revenue
$148K
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$473.7K
Analyze the earnings history of Ovid Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OVID | Ovid Therapeutics | -$0.18 | — | — | — | $75.00K | — | — | — | 08/02/2024 | Get Alert |
| OVID | Ovid Therapeutics | -$0.19 | -$0.22 | -$0.17 | 22.73% | $66.00K | $60.00K | $148.00K | 146.67% | 05/14/2024 | Get Alert |
| OVID | Ovid Therapeutics | -$0.16 | -$0.05 | -$0.22 | -340.00% | $46.28K | $60.00K | $141.56K | — | 03/08/2024 | Get Alert |
| OVID | Ovid Therapeutics | -$0.17 | -$0.19 | -$0.16 | 15.79% | $11.10K | $50.00K | $108.97K | 117.94% | 11/03/2023 | Get Alert |
| OVID | Ovid Therapeutics | -$0.21 | -$0.20 | -$0.18 | 10.00% | $0.00 | $50.00K | $75.00K | 50.00% | 08/04/2023 | Get Alert |
| OVID | Ovid Therapeutics | -$0.23 | -$0.17 | -$0.19 | -11.76% | $1.45M | $20.00K | $66.16K | 230.80% | 05/05/2023 | Get Alert |
| OVID | Ovid Therapeutics | -$0.38 | -$0.18 | -$0.16 | 11.11% | $0.00 | — | $46.28K | — | 03/13/2023 | Get Alert |
| OVID | Ovid Therapeutics | -$0.17 | -$0.21 | -$0.17 | 19.05% | $0.00 | — | $11.10K | — | 11/08/2022 | Get Alert |
| OVID | Ovid Therapeutics | -$0.23 | -$0.25 | -$0.21 | 16.00% | $0.00 | — | $0.00 | — | 08/09/2022 | Get Alert |
| OVID | Ovid Therapeutics | $2.53 | -$0.21 | -$0.23 | -9.52% | $208.38M | — | $1.45M | — | 05/10/2022 | Get Alert |
| OVID | Ovid Therapeutics | -$0.34 | -$0.16 | -$0.38 | -137.50% | $5.70M | — | $0.00 | — | 03/15/2022 | Get Alert |
| OVID | Ovid Therapeutics | -$0.28 | — | -$0.17 | — | $6.91M | — | $0.00 | — | 11/10/2021 | Get Alert |
| OVID | Ovid Therapeutics | -$0.41 | -$0.16 | -$0.23 | -43.75% | $0.00 | — | $0.00 | — | 08/16/2021 | Get Alert |
| OVID | Ovid Therapeutics | -$0.37 | -$0.14 | $2.53 | 1907.14% | $0.00 | $1.29M | $208.38M | 16053.72% | 05/13/2021 | Get Alert |
| OVID | Ovid Therapeutics | -$0.35 | — | -$0.34 | — | $0.00 | — | $5.70M | — | 03/15/2021 | Get Alert |
| OVID | Ovid Therapeutics | -$0.43 | -$0.36 | -$0.28 | 22.22% | $0.00 | $80.00K | $6.91M | 8542.50% | 11/12/2020 | Get Alert |
| OVID | Ovid Therapeutics | -$0.34 | -$0.36 | -$0.41 | -13.89% | $0.00 | — | $0.00 | — | 08/10/2020 | Get Alert |
| OVID | Ovid Therapeutics | -$0.46 | — | -$0.37 | — | $0.00 | — | $0.00 | — | 05/07/2020 | Get Alert |
| OVID | Ovid Therapeutics | -$0.52 | -$0.41 | -$0.35 | 14.63% | $0.00 | — | $0.00 | — | 03/11/2020 | Get Alert |
| OVID | Ovid Therapeutics | -$0.53 | — | -$0.43 | — | $0.00 | — | $0.00 | — | 11/08/2019 | Get Alert |
| OVID | Ovid Therapeutics | -$0.53 | — | -$0.34 | — | $0.00 | — | $0.00 | — | 08/07/2019 | Get Alert |
Ovid Therapeutics (OVID) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-14 | $-0.17 | $-0.22 | 22.7 % |
| Dec 2023 | 2024-03-08 | $-0.22 | $-0.05 | -340.0 % |
| Sep 2023 | 2023-11-03 | $-0.16 | $-0.19 | 15.8 % |
| Jun 2023 | 2023-08-04 | $-0.18 | $-0.20 | 10.0 % |
Ovid Therapeutics (OVID) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-14 | $148.00K | $60.00K | 146.7 % |
| Sep 2023 | 2023-11-03 | $108.97K | $50.00K | 117.9 % |
| Jun 2023 | 2023-08-04 | $75.00K | $50.00K | 50.0 % |
| Mar 2023 | 2023-05-05 | $66.16K | $20.00K | 230.8 % |
FAQ
When is Ovid Therapeutics (NASDAQ:OVID) reporting earnings?
Ovid Therapeutics (OVID) is scheduled to report earnings on August 2, 2024. The last reported earnings were for reported on May 14, 2024 for Q1.
What were the latest earnings per share (EPS) for Ovid Therapeutics (NASDAQ:OVID)?
The Actual EPS was $-0.17, which beat the estimate of $-0.22.
What were Ovid Therapeutics’s (NASDAQ:OVID) revenues?
The Actual Revenue was $148K, which beat the estimate of $60K.
Browse earnings estimates, EPS, and revenue on all stocks.